Trading Report: The 10,000 Shares of USANA Health Sciences Inc. (USNA) Stock are sold by Global Ltd Gull

The 10,000 Shares of USANA Health Sciences Inc. (USNA) Stock are sold by Global Ltd Gull

USANA Health Sciences Inc. (NYSE:USNA) major shareholder Global Ltd Gull sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, October 12th. The stock was sold at an average price of $146.35, for a total transaction of $1,463,500.00. Following the sale, the insider now owns 6,319,110 shares of the company’s stock, valued at $924,801,748.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Large shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Global Ltd Gull also recently made the following trade(s): On Wednesday, September 14th, Global Ltd Gull sold 10,000 shares of USANA Health Sciences stock. The stock was sold at an average price of $134.67, for a total transaction of $1,346,700.00. On Wednesday, August 10th, Global Ltd Gull sold 10,000 shares of USANA Health Sciences stock. The stock was sold at an average price of $135.08, for a total transaction of $1,350,800.00.

USANA Health Sciences Inc. (NYSE:USNA) opened at 147.20 on Tuesday. USANA Health Sciences Inc. has a 52 week low of $92.00 and a 52 week high of $150.00. The stock has a market capitalization of $1.77 billion, a P/E ratio of 19.40 and a beta of 1.34. The stock has a 50 day moving average of $139.49 and a 200 day moving average of $127.78.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings results on Tuesday, July 26th. The company reported $2.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.05 by $0.02. The business earned $258.50 million during the quarter, compared to analyst estimates of $256.66 million. USANA Health Sciences had a net margin of 10.07% and a return on equity of 34.15%. The firm’s revenue was up 10.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.92 earnings per share. On average, equities research analysts predict that USANA Health Sciences Inc. will post $8.10 earnings per share for the current fiscal year.

Several research analysts have recently weighed in on USNA shares. Zacks Investment Research downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 28th. DA Davidson upped their target price on shares of USANA Health Sciences from $135.00 to $150.00 and gave the company a “neutral” rating in a research note on Thursday, July 28th.

Several hedge funds have recently bought and sold shares of USNA. Legal & General Group Plc raised its stake in USANA Health Sciences by 30.9% in the second quarter. Legal & General Group Plc now owns 1,696 shares of the company’s stock worth $186,000 after buying an additional 400 shares during the period. Quadrature Capital Ltd bought a new stake in USANA Health Sciences during the second quarter worth about $242,000. BlackRock Inc. raised its stake in USANA Health Sciences by 467.7% in the second quarter. BlackRock Inc. now owns 2,447 shares of the company’s stock worth $273,000 after buying an additional 2,016 shares during the period. Trexquant Investment LP bought a new stake in USANA Health Sciences during the second quarter worth about $299,000. Finally, Cubist Systematic Strategies LLC bought a new stake in USANA Health Sciences during the second quarter worth about $305,000. 41.85% of the stock is owned by institutional investors and hedge funds.

USANA Health Sciences Company Profile

Related posts

Leave a Comment